Abstract：
BACKGROUND: Iliofemoral venous stent placement (IVS) has evolved to a well-established endovascular treatment modality for chronic iliofemoral venous obstruction (CIVO). Dedicated venous stents gained approval from the US Food and Drug Administration in 2019 and solidified IVS as a defined intervention with clear indications, contraindications, risks, benefits, and procedural management principles. This review focuses on the indications, technical aspects and outcomes of stenting for CIVO. Other aspects pertaining to IVS are covered in other articles that are a part of this series.
METHODS: This study conducted a literature search limited to English articles. Three search strategies were used, and references were managed in Covidence software. Four investigators screened and evaluated articles independently, excluding meta-analyses, clinical trial protocols, and nonrelevant studies. Eligible studies, focused on clinical outcomes and stent patencies, underwent thorough review.
RESULTS: The literature search yielded 1704 studies, with 147 meeting eligibility criteria after screening and evaluation. Exclusions were based on duplicates, irrelevant content, and noniliac vein stent placement.
CONCLUSIONS: Successful IVS for CIVO relies on meticulous patient selection, consistent use of intravascular ultrasound examination during procedures and attention to the technical details of IVS.
METHODS: This study conducted a literature search limited to English articles. Three search strategies were used, and references were managed in Covidence software. Four investigators screened and evaluated articles independently, excluding meta-analyses, clinical trial protocols, and nonrelevant studies. Eligible studies, focused on clinical outcomes and stent patencies, underwent thorough review.
RESULTS: The literature search yielded 1704 studies, with 147 meeting eligibility criteria after screening and evaluation. Exclusions were based on duplicates, irrelevant content, and noniliac vein stent placement.
CONCLUSIONS: Successful IVS for CIVO relies on meticulous patient selection, consistent use of intravascular ultrasound examination during procedures and attention to the technical details of IVS.
摘要：
背景：髂股静脉支架置入术（IVS）已发展成为一种完善的慢性髂股静脉阻塞（CIVO）的血管内治疗方式。专用静脉支架于2019年获得FDA批准，并将IVS作为明确的干预措施，具有明确的适应症，禁忌症,风险,好处,和程序化管理原则。这篇综述的重点是适应症，CIVO支架术的技术方面和结果。与IVS有关的其他方面包含在本系列的手稿中。
方法：本研究仅针对英文文章进行文献检索。采用了三种搜索策略，和参考文献在Covidence软件中管理。四名研究者独立筛选和评估文章，不包括荟萃分析，临床试验方案，和无关的研究。符合条件的研究，专注于临床结果和支架通畅，进行了彻底的审查。
结果：文献检索产生了1,704项研究，在筛选和评估后，147人符合资格标准。排除基于重复项，无关内容,非髂静脉支架置入术。
结论：成功的IVS对于CIVO依赖于细致的患者选择，在手术过程中持续使用IVUS，并注意IVS的技术细节。
方法：本研究仅针对英文文章进行文献检索。采用了三种搜索策略，和参考文献在Covidence软件中管理。四名研究者独立筛选和评估文章，不包括荟萃分析，临床试验方案，和无关的研究。符合条件的研究，专注于临床结果和支架通畅，进行了彻底的审查。
结果：文献检索产生了1,704项研究，在筛选和评估后，147人符合资格标准。排除基于重复项，无关内容,非髂静脉支架置入术。
结论：成功的IVS对于CIVO依赖于细致的患者选择，在手术过程中持续使用IVUS，并注意IVS的技术细节。
